The Leadership Team at Genevant Sciences is responsible for setting strategic direction and driving innovation in nucleic acid delivery technologies. Comprising key executives such as the CEO, Chief Scientific Officer, and VPs of Pharmaceutical Development and Quality, this team collaborates closely with external partners and internal stakeholders to ensure the successful development and commercialization of cutting-edge therapies. Their combined expertise in drug development, regulatory affairs, and legal oversight positions Genevant as a leader in the biopharmaceutical industry.
View all